BRIM Biotechnology, Inc. (TPE:6885)
Taiwan · Delayed Price · Currency is TWD 27.70
-0.30 (-1.07%)
At close: Jan 21, 2026
BRIM Biotechnology Revenue
BRIM Biotechnology had revenue of 1.23M TWD in the quarter ending September 30, 2025, with 1,762.12% growth. This brings the company's revenue in the last twelve months to 3.17M, up 1,933.33% year-over-year. In the year 2024, BRIM Biotechnology had annual revenue of 333.00K with 270.00% growth.
Revenue (ttm)
3.17M
Revenue Growth
+1,933.33%
P/S Ratio
1,163.31
Revenue / Employee
99.13K
Employees
32
Market Cap
3.69B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 333.00K | 243.00K | 270.00% |
| Dec 31, 2023 | 90.00K | -436.00K | -82.89% |
| Dec 31, 2022 | 526.00K | 166.00K | 46.11% |
| Dec 31, 2021 | 360.00K | -90.41M | -99.60% |
| Dec 31, 2020 | 90.77M | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Syngen Biotech | 2.13B |
| SYN-TECH Chem. & Pharm. | 1.29B |
| Genovate Biotechnology | 491.23M |
| Sagittarius Life Science | 424.44M |
| 3D Global Biotech | 324.87M |
| Intech Biopharm | 113.85M |
| GlycoNex Incorporation | 36.63M |
| ACRO Biomedical | 36.50M |